Gary I Kleiner, MD, PhD

Dr Joacir Graciolli is a neurological surgeon who specializes in the surgical treatment of brain and spinal disorders of the nervous system. His areas of interest are neurotrauma, chronic pain (including spinal cord stimulation), degenerative spinal disorders, spasticity, epilepsy (VNS) as well as robotic surgery for trigeminal neuralgia. He is also interested in the study of complex multi-modal monitoring, neuroaugmentative and neuroregenerative approaches for the treatment of critically ill patients with traumatic brain injury with the goal of optimizing functional outcome. Dr Graciolli is Board Certified in Neurological Surgery from the Brazilian Society of Neurosurgery and by the LandesÃrztekammer Baden-WÃrttemberg.

Dr Gilberto Lopes is a medical oncologist and researcher who focuses on new anticancer drug development and global oncology. He has published more than 270 scientific papers and has led hundreds of clinical trials. Dr Lopes was the main investigator of Keynote 42, a clinical trial that demonstrated the efficacy of the immunotherapy drug pembrolizumab in people living with lung cancer. This groundbreaking study led to one of the FDA approvals of pembrolizumab. Additionally, Dr Lopes has contributed significantly to the development of several chemotherapies and targeted medications that address specific molecular changes in tumors.